STAT News: Second Ebola vaccine set to be used soon in Democratic Republic of Congo

The first batch of the Ad26.ZEBOV/MVA-BN-Filo vaccine—manufactured by Johnson & Johnson—has arrived in Goma. The start of the study is scheduled for November 14.
Democratic Republic of Congo 2019 © Gabriella Bianchi/MSF
Click to hide Text

The Democratic Republic of Congo’s Ministry of Health will soon introduce a new Ebola vaccine manufactured by Johnson & Johnson as part of a large-scale clinical study in areas of the country affected by the ongoing Ebola epidemic. Doctors Without Borders/Médecins Sans Frontières (MSF) will be a partner in a consortium of international organizations involved in planning and implementing the study. View external media